Male infertility tablet15 May 2021 14:27
In 2021 St George Street is looking to start a Phase II clinical trial in Idiopathic Male Infertility. Male infertility is a completely neglected area of the pharmaceutical industry, however 1 in 6 couples will experience infertility and in 50% of these cases male factor infertility is a significant cause. The only proven treatments for idiopathic male infertility at present involve artificial reproductive technologies (ART) including a specialised form of IVF called ICSI. This is extremely invasive for the woman involving multiple weeks of high dose hormone self-injection, multiple intravaginal scans and egg harvesting. In the UK right now, the number one reason why couples require IVF therapy is actually male infertility, not female infertility. St George Street is looking to change this treatment paradigm, with a new therapy that looks to treat male factor infertility directly. The proposed Ph II trial is expected to involve 150-200 patients who will be given an oral tablet for 3 months to investigate if this oral therapy improves sperm parameters to improve the chances of a successful pregnancy. Here at St George Street, we passionately believe in the need for such a treatment with a huge community of both men and women calling for new treatments. We know that current treatments using ART come at a high financial and mental-health cost. We want to change that. Keep up to date with our progress through our website and twitter account @st_capital.